DNAM-1 control of natural killer cells functions through nectin and nectin-like proteins (Q30716850)

26 June 2017

DNAM-1 control of natural killer cells functions through nectin and nectin-like proteins (English)

1 reference

26 June 2017

Lucas Ferrari de Andrade

object named as

Lucas Ferrari de Andrade

series ordinal

1

0 references

Ludovic Martinet

object named as

Ludovic Martinet

series ordinal

3

0 references

Mark J. Smyth

object named as

Mark J Smyth

series ordinal

2

0 references

publication date

17 December 2013

1 reference

Immunology & Cell Biology

26 June 2017

1 reference

26 June 2017

92

1 reference

26 June 2017

3

1 reference

26 June 2017

237-244

1 reference

Functions of natural killer cells

26 June 2017

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Up on the tightrope: natural killer cell activation and inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Controlling natural killer cell responses: integration of signals for activation and inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Regulation of human NK-cell cytokine and chemokine production by target cell recognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Receptors that interact with nectin and nectin-like proteins in the immunosurveillance and immunotherapy of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Biology and pathology of nectins and nectin-like molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Molecular mechanisms of natural killer cell activation in response to cellular stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

TLiSA1, a human T lineage-specific activation antigen involved in the differentiation of cytotoxic T lymphocytes and anomalous killer cells from their precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Tumor rejection by the poliovirus receptor family ligands of the DNAM-1 (CD226) receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Mouse TIGIT inhibits NK-cell cytotoxicity upon interaction with PVR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Physical and functional association of LFA-1 with DNAM-1 adhesion molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

The LFA-1-associated molecule PTA-1 (CD226) on T cells forms a dynamic molecular complex with protein 4.1G and human discs large

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

The MAGUK family protein CARD11 is essential for lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

GAKIN, a novel kinesin-like protein associates with the human homologue of the Drosophila discs large tumor suppressor in T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

CARD11 and CARD14 are novel caspase recruitment domain (CARD)/membrane-associated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Multiple ITAM-coupled NK-cell receptors engage the Bcl10/Malt1 complex via Carma1 for NF-kappaB and MAPK activation to selectively control cytokine production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Synergistic signals for natural cytotoxicity are required to overcome inhibition by c-Cbl ubiquitin ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Complementary phosphorylation sites in the adaptor protein SLP-76 promote synergistic activation of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Accelerated tumor growth in mice deficient in DNAM-1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

DNAM-1/CD155 interactions promote cytokine and NK cell-mediated suppression of poorly immunogenic melanoma metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

ATM-dependent spontaneous regression of early Eμ-myc-induced murine B-cell leukemia depends on natural killer and T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

The DNA damage response arouses the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Intranodal interaction with dendritic cells dynamically regulates surface expression of the co-stimulatory receptor CD226 protein on murine T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

CD8 T cell defect of TNF-α and IL-2 in DNAM-1 deficient mice delays clearance in vivo of a persistent virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Human cytomegalovirus UL141 promotes efficient downregulation of the natural killer cell activating ligand CD112

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Toll-like receptor ligands induce expression of the costimulatory molecule CD155 on antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

The human immunodeficiency virus type 1 Vpr protein upregulates PVR via activation of the ATR-mediated DNA damage response pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cell-activating ligand PVR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Loss of DNAM-1 contributes to CD8+ T-cell exhaustion in chronic HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Tissue-specific homing and expansion of donor NK cells in allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

DNAM-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: relevance for NK-T cell interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

CD226 Gly307Ser association with multiple autoimmune diseases: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Association between the CD226 rs763361 polymorphism and susceptibility to autoimmune diseases: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Association of the CD226 single nucleotide polymorphism with systemic lupus erythematosus in the Chinese Han population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Non-synonymous variant (Gly307Ser) in CD226 is associated with susceptibility to multiple autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Novel association of the CD226 (DNAM-1) Gly307Ser polymorphism in Wegener's granulomatosis and confirmation for multiple sclerosis in German patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

CD226 (DNAM-1) is involved in lymphocyte function-associated antigen 1 costimulatory signal for naive T cell differentiation and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

CD226 is specifically expressed on the surface of Th1 cells and regulates their expansion and effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

The CD226/CD155 interaction regulates the proinflammatory (Th1/Th17)/anti-inflammatory (Th2) balance in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Natural killer cells in human autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Reciprocal regulation between natural killer cells and autoreactive T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Role of natural killer cells and TCR gamma delta T cells in acute autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Mobilization of natural killer cells inhibits development of collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Regulatory T cells control NK cells in an insulitic lesion by depriving them of IL-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

A novel molecular interaction for the adhesion of follicular CD4 T cells to follicular DC

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Vstm3 is a member of the CD28 family and an important modulator of T-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Cutting edge: TIGIT has T cell-intrinsic inhibitory functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

The TIGIT/CD226 axis regulates human T cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Recruitment of Grb2 and SHIP1 by the ITT-like motif of TIGIT suppresses granule polarization and cytotoxicity of NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Cutting edge: CD96 (tactile) promotes NK cell-target cell adhesion by interacting with the poliovirus receptor (CD155)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

The murine pan T cell marker CD96 is an adhesion receptor for CD155 and nectin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

CD96 interaction with CD155 via its first Ig-like domain is modulated by alternative splicing or mutations in distal Ig-like domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

The expanding world of co-stimulation: the two-signal model revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

Natural killer cell recognition of missing self

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

7 January 2021

Decreased expression of DNAM-1 on NK cells from acute myeloid leukemia patients

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

7 January 2021

Prevention of graft versus host disease by inactivation of host antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

7 January 2021

Natural killer cells expressing the KIR2DS1-activating receptor efficiently kill T-cell blasts and dendritic cells: implications in haploidentical HSCT

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

7 January 2021

Immunological aspects of cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FICB.2013.95

7 January 2021

Identifiers

DOI

10.1038/ICB.2013.95

1 reference

26 June 2017

1 reference

PubMed ID

24343663